Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Guillermina Lozano

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8985-4886; OpenAlex author ID A5076622040; NIH RePORTER profile ID 7748957. Sources: OpenAlex.

Their work

Papers
1 (first author 0, last author 1)
Trials
0
Grants
2
Labs led
1
Collaborators
11
Papers, trials and grants by year

2017: 1 grant · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 grant

Papers 1

  1. Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis. Last author DOI 10.1158/2159-8290.cd-20-1228↗

Grants 2

  1. A Pathway of Tumor Suppression R01CA047296↗
  2. (PQ4) Mutations in the histone chaperone DAXX drive pancreatic neuroendocrine tumors not ductal adenocarcinomas R21CA208463↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xinqun Li · 1 shared paper, 2021 · strength 0.10
  2. Ya’an Kang · 1 shared paper, 2021 · strength 0.10
  3. Bingbing Dai · 1 shared paper, 2021 · strength 0.10
  4. Timothy Paul Heffernan · 1 shared paper, 2021 · strength 0.10
  5. Bin Liu · 1 shared paper, 2021 · strength 0.10
  6. Jenying Deng · 1 shared paper, 2021 · strength 0.10
  7. Jason B. Fleming · 1 shared paper, 2021 · strength 0.10
  8. Michael P. Kim · 1 shared paper, 2021 · strength 0.10
  9. Anirban Maitra · 1 shared paper, 2021 · strength 0.10
  10. Eugene Jon Koay · 1 shared paper, 2021 · strength 0.10
  11. Florencia M. McAllister · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.